U.S. OKs use of Genentech's Avastin in lung cancer
(Re


Reuters - U.S. regulators agreed to expand
the use of Genentech Inc.'s drug Avastin, now used against
colon cancer, to include treatment of the most common type of
lung cancer, the company said on Wednesday.